This is a preview of subscription content, log in via an institution to check access.
Notes
including decompensated cirrhosis, liver cancer, liver transplant and liver-related death
2013 euros
Reference
Athanasakis K, et al. Boceprevir for Chronic Genotype 1 Hepatitis C Virus in the Current Health Care Setting in Greece: A Cost-Effectiveness Analysis. Clinical Therapeutics : 29 May 2015. Available from: URL: http://doi.org/10.1016/j.clinthera.2015.05.003
Rights and permissions
About this article
Cite this article
Addition of boceprevir to PEG + RBV cost effective in Greece. PharmacoEcon Outcomes News 731, 8 (2015). https://doi.org/10.1007/s40274-015-2237-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2237-0